Artículos Científicos

DATE: 2019/01/19
Treatment retention in a specialized alcohol programme after an episode of alcoholic hepatitis: Impact on alcohol relapse
J Psychosom Res. 2019 Jan;116:75-82. doi: 10.1016/j.jpsychores.2018.11.020. Epub 2018 Nov 28.
AUTHORS: López-Pelayo H, Miquel L, Altamirano J, Bataller R, Caballeria J, Ortega L, Lligoña A, Gual A.
PMID: 30654998
DATE: 2018/07/31
A comparison between phase-III trials and a phase-IV study of nalmefene in alcohol use disorder patients. Is there a difference?
Adicciones. 2019 Sep 1;31(4):284-288. doi: 10.20882/adicciones.1046.
AUTHORS: Barrio Giménez P, Ortega L, Guardia J, Roncero C, Yuguero L, Gual A.
PMID: 30059574
DATE: 2015/08/14
Psychiatric Comorbidity in Treatment-Seeking Alcohol Dependence Patients With and Without ADHD
J Atten Disord. 2019 Oct;23(12):1497-1504. doi: 10.1177/1087054715598841. Epub 2015 Aug 12.
AUTHORS: Roncero C, Ortega L, Pérez-Pazos J, Lligoña A, Abad AC, Gual A, Sorribes M, Grau-López L, Casas M, Daigre C.
PMID: 26269096
DATE: 2018/10/04
Risky Alcohol Use: The Impact on Health Service Use
Eur Addict Res. 2018;24(5):234-244. doi: 10.1159/000493884. Epub 2018 Oct 3.
AUTHORS: Miquel L, Manthey J, Rehm J, Vela E, Bustins M, Segura L, Vieta E, Colom J, Anderson P, Gual A.
PMID: 30282079
DATE: 2018/09/12
New Alcohol Biomarkers. New challenges
Alcohol Alcohol. 2018 Nov 1;53(6):762-763. doi: 10.1093/alcalc/agy064.
AUTHORS: Barrio P, Wurst FM, Gual A.
PMID: 30204846
DATE: 2018/08/30
Publisher Correction: Alcoholic liver disease
Nat Rev Dis Primers. 2018 Aug 28;4(1):18. doi: 10.1038/s41572-018-0021-8.
AUTHORS: Seitz HK, Bataller R, Cortez-Pinto H, Gao B, Gual A, Lackner C, Mathurin P, Mueller S, Szabo G, Tsukamoto H.
PMID: 30154473
DATE: 2018/08/23
A Survey on the Medical Use of Cannabis in Europe: A Position Paper
Eur Addict Res. 2018;24(4):201-205. doi: 10.1159/000492757. Epub 2018 Aug 22.
AUTHORS: Bramness JG, Dom G, Gual A, Mann K, Wurst FM.
PMID: 30134238
DATE: 2018/08/18
Alcoholic liver disease
Nat Rev Dis Primers. 2018 Aug 16;4(1):16. doi: 10.1038/s41572-018-0014-7.
AUTHORS: Seitz HK, Bataller R, Cortez-Pinto H, Gao B, Gual A, Lackner C, Mathurin P, Mueller S, Szabo G, Tsukamoto H.
PMID: 30115921
DATE: 2018/07/31
Quality of life role in risky alcohol use research: should it be a more relevant outcome in any study?
Adicciones. 2018 Jul 13;30(4):301-303. doi: 10.20882/adicciones.1098.
AUTHORS: López-Pelayo H, Oliveras C, Segura L, Colom J, Díaz E, Wallace P, Gual A.
PMID: 30059591
DATE: 2018/07/26
Efficacy and safety of sodium oxybate in alcohol-dependent patients with a very high drinking risk level
Addict Biol. 2018 Jul;23(4):969-986. doi: 10.1111/adb.12645.
AUTHORS: van den Brink W, Addolorato G, Aubin HJ, Benyamina A, Caputo F, Dematteis M, Gual A, Lesch OM, Mann K, Maremmani I, Nutt D, Paille F, Perney P, Rehm J, Reynaud M, Simon N, Söderpalm B, Sommer WH, Walter H, Spanagel R.
PMID: 30043457